Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126454622 | 12645462 | 2 | F | 20160927 | 20160811 | 20160929 | PER | PHEH2016US020120 | NOVARTIS | 0.00 | F | Y | 100.23000 | KG | 20160929 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126454622 | 12645462 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 1-2, 0.062 MG, (0.25 ML), QOD | 54223-1A | 125290 | .062 | MG | SOLUTION FOR INJECTION | ||||||
| 126454622 | 12645462 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 3-4, 0.125 MG, (0.5 ML), QOD | 54223-1A | 125290 | .125 | MG | SOLUTION FOR INJECTION | ||||||
| 126454622 | 12645462 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 5-6, 0.187 MG,(0.75 ML), QOD | 54223-1A | 125290 | .187 | MG | SOLUTION FOR INJECTION | ||||||
| 126454622 | 12645462 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 7 AND ABOVE: 0.25 MG,(1 ML), QOD AND MAINTAINENCE | 54223-1A | 125290 | .25 | MG | SOLUTION FOR INJECTION | ||||||
| 126454622 | 12645462 | 5 | C | ORENCIA | ABATACEPT | 1 | Unknown | QW | U | 0 | INJECTION | /wk | |||||||
| 126454622 | 12645462 | 6 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | D | 0 | ||||||||||
| 126454622 | 12645462 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 126454622 | 12645462 | 8 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126454622 | 12645462 | 1 | Multiple sclerosis |
| 126454622 | 12645462 | 5 | Rheumatoid arthritis |
| 126454622 | 12645462 | 6 | Rheumatoid arthritis |
| 126454622 | 12645462 | 7 | Rheumatoid arthritis |
| 126454622 | 12645462 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126454622 | 12645462 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126454622 | 12645462 | Headache | |
| 126454622 | 12645462 | Hyperhidrosis | |
| 126454622 | 12645462 | Injection site erythema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126454622 | 12645462 | 1 | 20160608 | 0 |